Webinar
Are you stable or transient? Optimize your biotherapeutic cell line workflows
Jounce Therapeutics successfully integrated the CHOSOURCE platform to help build efficiencies across their drug development workflow. Michael Cullivan from Jounce highlights the benefits of transient and stable transfections of CHO cell lines for various production purposes using their own experiences.
Hear about:
- Transiently transfecting CHO-GS cells to produce material within a short time frame
- Testing involved to achieve sufficient titer and repeatability
- Optimization of protocols to streamline processes
The CHOSURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.